Clinical Trial

Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells

Recruiting
View on ClinicalTrials.gov →
Summary
Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation. The major goal of the project is to develop human iPS cells from existing lines of fibroblasts that were originally donated as clinical grade feeders for the development of clinical grade hESCs. The clinical grade feeders were developed from aborted fetuses, foreskin and umbilical cord.
Protocol Amendment History 29 amendments
This ClinicalTrials.gov record has been amended 29 times since 2008-12-02; most recent amendment 2025-03-17.
Status change: Active, Not Recruiting → Recruiting 2025-03-17
Status change: Recruiting → Active, Not Recruiting 2024-02-29
Status change: Active, Not Recruiting → Recruiting 2016-09-01
Trial Details
NCT Number NCT00801372
Lead Sponsor Hadassah Medical Organization
Conditions Pregnant, Healthy Females, Healthy Male Newborns
Enrollment 1 participants
Start Date 2008-11
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-19